Patrick Trucchio
Recent Articles about Milestone Pharmaceuticals Inc.
PDUFA Date Nearing for New PSVT Drug 03/19/2025
If approved, commercialization will start mid-year; the biopharma behind the treatment offers a potential return of 1,052%, noted an H.C. Wainwright & Co. report.
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
